Purpose

The purpose of this research trial is to evaluate the effect of two types of washing solutions on wound healing after total hip replacement surgery. Washing solutions are used routinely during total hip replacements to clean the wound after the components have been placed and the wound is about to be closed with sutures. It is currently not known which washing solution may be better for wound healing and whether a certain solution decreases the risk of wound healing complications after total hip replacement. Therefore, this research trial is being conducted. Study participants will be randomized into one of two groups: washing the surgical wound with povidone-iodine solution (Surgiphor, Becton Dickinson, Franklin Lakes, NJ) or chlorhexidine solution (Irrisept, Irrimax Corporation, Lawrenceville, GA). All patients will undergo standard of care total hip replacements without any other change in surgery. The best type of solution that cleans the wound and potentially leads to better wound healing is unknown. This study will evaluate whether there is difference in surgical wound healing between the two washing solutions. The study will pay for the washing solutions. Patients will follow up for standard postoperative visits. At the 2-week and 6-week visits, pictures of the surgical incision will be taken and saved in the electronic medical record and evaluated in a standardized way for healing of the incision and the appearance of the scar. Postoperative complications and returns to the hospital or additional surgeries will be collected from the electronic medical record.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • osteoarthritis or avascular necrosis of the femoral head, failed conservative management, indicated for total hip replacement

Exclusion Criteria

  • reported or documented allergy to chlorhexidine or povidone-iodine

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Chlorhexidine washing solution
Following component implantation a 3-minute chlorhexidine lavage followed by saline lavage will be performed.
  • Device: lavage chlorhexidine
    Patient will receive a chlorhexidine lavage for 3 minutes following total hip component placement followed by saline lavage.
Experimental
Povidone-iodine washing solution
Following component implantation a 3-minute povidone-iodine lavage followed by saline lavage will be performed.
  • Device: lavage povidone-iodine
    Patient will receive povidone-iodine lavage for 3 minutes following total hip component placement followed by saline lavage.

Recruiting Locations

UPMC East
Monroeville 5201734, Pennsylvania 6254927 15146
Contact:
Dana Farrell, BS,PMP
(412) 383-0955
djf52@pitt.edu

UPMC Shadyside
Pittsburgh 5206379, Pennsylvania 6254927 15232
Contact:
Dana Farrell, BS,PMP
(412) 383-0955
djf52@pitt.edu

More Details

NCT ID
NCT07104084
Status
Recruiting
Sponsor
F. Johannes Plate

Study Contact

Frank J Plate, MD, PhD
(412) 687-3900
platefj2@upmc.edu

Detailed Description

Study participants will be randomized into one of two groups: washing the surgical wound with povidone-iodine solution (Surgiphor, Becton Dickinson, Franklin Lakes, NJ) or chlorhexidine solution (Irrisept, Irrimax Corporation, Lawrenceville, GA). All patients will undergo standard of care total hip replacements without any other change in surgery. The best type of solution that cleans the wound and potentially leads to better wound healing is unknown. This study will evaluate whether there is difference in surgical wound healing between the two washing solutions. Patients will follow up for standard postoperative visits. At the 2-week and 6-week visits, pictures of the surgical incision will be taken and saved in the electronic medical record and evaluated in a standardized way for healing of the incision and the appearance of the scar. Postoperative complications and returns to the hospital or additional surgeries will be collected from the electronic medical record.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.